Characterization of a New Metallo-β-Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India
By D. Yong, M. Toleman, C. Giske, Hyun-soo Cho, K. Sundman, Kyungwon Lee, T. Walsh. Antimicrobial Agents and Chemotherapy, 2009
2,458 citations recorded by the source corpus.
ABSTRACT A Swedish patient of Indian origin traveled to New Delhi, India, and acquired a urinary tract infection caused by a carbapenem-resistant Klebsiella pneumoniae strain that typed to the sequence type 14 complex. The isolate, Klebsiella pneumoniae 05-506, was shown to possess a metallo-β-lactamase (MBL) but was negative for previously known MBL genes. Gene libraries and amplification of class 1 integrons revealed three resistance-conferring regions; the first contained blaCMY-4 flanked by ISEcP1 and blc. The second region of 4.8 kb contained a complex class 1 integron with the gene cassettes arr-2, a new erythromycin esterase gene; ereC; aadA1; and cmlA7. An intact ISCR1 element was shown to be downstream from the qac/sul genes. The third region consisted of a new MBL gene, designated blaNDM-1, flanked on one side by K. pneumoniae DNA and a truncated IS26 element on its other side. The last two regions lie adjacent to one another, and all three regions are found on a 180-kb region that is easily transferable to recipient strains and that confers resistance to all antibiotics except fluoroquinolones and colistin. NDM-1 shares very little identity with other MBLs, with the most similar MBLs being VIM-1/VIM-2, with which it has only 32.4% identity. As well as possessing unique residues near the active site, NDM-1 also has an additional insert between positions 162 and 166 not present in other MBLs. NDM-1 has a molecular mass of 28 kDa, is monomeric, and can hydrolyze all β-lactams except aztreonam. Compared to VIM-2, NDM-1 displays tighter binding to most cephalosporins, in particular, cefuroxime, cefotaxime, and cephalothin (cefalotin), and also to the penicillins. NDM-1 does not bind to the carbapenems as tightly as IMP-1 or VIM-2 and turns over the carbapenems at a rate similar to that of VIM-2. In addition to K. pneumoniae 05-506, blaNDM-1 was found on a 140-kb plasmid in an Escherichia coli strain isolated from the patient's feces, inferring the possibility of in vivo conjugation. The broad resistance carried on these plasmids is a further worrying development for India, which already has high levels of antibiotic resistance.
Subfields: Infectious Diseases, Molecular Medicine
View Paper: https://www.semanticscholar.org/paper/2e1362a9ce281e56b51a950c8839e2ff6aeed46f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Infectious Diseases
- M. Huemer
- J. Pitout
- S. Brugger
- Gerard D. Wright
- Robert A. Bonomo
- Annelies S. Zinkernagel
- P. Nordmann
- L. Poirel
In Molecular Medicine
Citations in the corpus
- The global epidemiology of carbapenemase-producing Enterobacteriaceae (2017, background): “through production of a novel carbapenemase designated NDM-1.(45) A follow-up study showed that NDM-1-medi-”
- Global Spread of Carbapenemase-producing Enterobacteriaceae (2011, background): “Discovered in 2008 in Sweden from an Indian patient hospitalized previously in New Delhi (15), NDM-”
- The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace (2017, background): “pneumoniae with a new MBL gene, blaNDM-1, from a Swedish patient who received healthcare in New Delhi, India [48].”
- Epidemiology of β-Lactamase-Producing Pathogens (2020, background): “In contrast, KPC serine carbapenemases are present more frequently in the Americas, the Mediterranean countries, and China, whereas NDM metallo- -lactamases are more prevalent in the Indian subcontinent and Eastern Europe.”
- Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: an Evolving Crisis of Global Dimensions (2012, background): “FN396876) (273) and by plasmid p271A (GenBank accession no.”
- The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. (2014, background): “Walsh TR, Weeks J, Livermore DM, Toleman MA. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study.”
- Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. (2012, background): “The NDM-producing K. pneumoniae isolates have been associated with ST14, ST11, and ST525 [8,177] (Ø. Samuelsen unpublished data), whereas the plasmid epidemiology has been less well studied, with the exception of the identification of NDM-1 on an IncA/C plasmid in an isolate from Denmark [181].”
- The Comprehensive Antibiotic Resistance Database (2013, background): “Aminoglycoside nucleotidyltransferases ANT(2 ), ANT(3 ), ANT(4=), ANT(6), ANT(9) Aminoglycoside phosphotransferases APH(2 ), APH(3 ), APH(3=), APH(4), APH(6), APH(7 ), APH(9) 16S rRNA methyltransferases ArmA, RmtA, RmtB, RmtC, Sgm -Lactams Class A -lactamases AER, BLA1, CTX-M, KPC, SHV, TEM, etc.b C”
- Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology. (2015, background): “Class B ˇ-lactamases These -lactamases, also named metallo- -lactamases (MBLs), hydrolyse carbapenems and other -lactams (except monobactams) very efficiently and they are not inhibited by the clinically available -lactamase inhibitors such as clavulanic acid or tazobactam.”
- Carbapenem resistance: overview of the problem and future perspectives (2016, result): “GIM, SIM, AIM, DIM, FIM and POM were reported only sporadically to date in contrast with NDM, which presented a spectacular global spread since its detection in 2008 in India [Yong et al. 2009].”
- Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance (2017, background): “Although other carbapenemase genes occured in K. pneumoniae and were even reported in this species for the first time, such as blaOXA-48 (Poirel et al. 2004) and blaNDM-1 (Yong et al. 2009), it is undoubtable that blaKPC became the most prevalent and highly impacting carbapenemase in K. pneumoniae.”